KCT0003149
Completed
未知
Clinical comparison study to evaluate the efficacy between tourniquet for blocking peripheral blood flow with minimal pressure sensor in primary total knee arthroplasty
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Seoul National University Hospital
- Enrollment
- 98
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The inclusion criterion was patients with primary osteoarthritis between 50 and 80 years old who were scheduled for primary TKA
Exclusion Criteria
- •patients below 50, and over 81 years of age
- •patients on antiplatelets
- •patients with coagulopathy disease
- •patients with a history of DVT
- •patients with peripheral nerve palsy
- •patients who underwent surgery of the lower limb
- •patients with a history of past psychological illness
- •patients diagnosed with cancerous condition
- •patients Participating in other studies
- •patients with Parkinson's disease, sequelae of poliomyelitis, stroke,
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Clinical comparison study to evaluate the efficacy between tourniquets in surgery for distal radius fracturesKCT0003456Seoul National University Hospital98
Completed
Phase 2
Medicated Nasal Drops and Head massage in NidranashHealth Condition 1: F419- Anxiety disorder, unspecifiedCTRI/2022/11/047392ational institute of ayurveda jaipur30
Not yet recruiting
Phase 1
Clinical Study to Assess the Efficacy of Kushmand Awaleha and Suvarna Prashana in Respiratory Allergic Disorders in ChildreHealth Condition 1: J684- Chronic respiratory conditions dueto chemicals, gases, fumes and vaporsCTRI/2024/08/072261Banaras Hindu University
Not yet recruiting
Phase 3
A Clinical Trial to study the effect of nagaradi tailam in SNHCTRI/2023/06/054585Dr Manjusha Mundhe
Recruiting
Phase 4
Immusante tablets in management of Chemotherapy induced NeutropeniaHealth Condition 1: null- Cancer subjects with chemotherapy induced neutropeniaCTRI/2018/05/013927The Himalaya Drug Company